ロード中...
Activation of preexisting T cell clones by targeted interleukin 2 therapy
The induction of an immunological antitumor response capable of eradicating metastatic tumors is the ultimate goal of immunotherapy. We have recently shown that this can be achieved by interleukin 2 (IL-2) therapy directed to the tumor microenvironment by a recombinant antibody–IL-2 fusion protein....
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The National Academy of Sciences
1998
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC21154/ https://ncbi.nlm.nih.gov/pubmed/9671756 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|